• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回顾性分析具有连续或二分类结局的临床试验中的条件功效假设。

A retrospective analysis of conditional power assumptions in clinical trials with continuous or binary endpoints.

机构信息

School of Health and Related Research, The University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, UK.

Intensive Care National Audit and Research Centre (ICNARC), 24 High Holborn, London, WC1V 6AZ, UK.

出版信息

Trials. 2023 Mar 22;24(1):215. doi: 10.1186/s13063-023-07202-6.

DOI:10.1186/s13063-023-07202-6
PMID:36949524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10035140/
Abstract

BACKGROUND

Adaptive clinical trials may use conditional power (CP) to make decisions at interim analyses, requiring assumptions about the treatment effect for remaining patients. It is critical that these assumptions are understood by those using CP in decision-making, as well as timings of these decisions.

METHODS

Data for 21 outcomes from 14 published clinical trials were made available for re-analysis. CP curves for accruing outcome information were calculated using and compared with a pre-specified objective criteria for original and transformed versions of the trial data using four future treatment effect assumptions: (i) observed current trend, (ii) hypothesised effect, (iii) 80% optimistic confidence limit, (iv) 90% optimistic confidence limit.

RESULTS

The hypothesised effect assumption met objective criteria when the true effect was close to that planned, but not when smaller than planned. The opposite was seen using the current trend assumption. Optimistic confidence limit assumptions appeared to offer a compromise between the two, performing well against objective criteria when the end observed effect was as planned or smaller.

CONCLUSION

The current trend assumption could be the preferable assumption when there is a wish to stop early for futility. Interim analyses could be undertaken as early as 30% of patients have data available. Optimistic confidence limit assumptions should be considered when using CP to make trial decisions, although later interim timings should be considered where logistically feasible.

摘要

背景

适应性临床试验可以使用条件功效(CP)在中期分析时做出决策,这需要对剩余患者的治疗效果做出假设。对于那些在决策中使用 CP 的人来说,了解这些假设以及这些决策的时间至关重要。

方法

为重新分析从 14 项已发表临床试验中获得了 21 个结局的数据。使用四种未来治疗效果假设(i)观察到的当前趋势、(ii)假设效果、(iii)80%乐观置信限、(iv)90%乐观置信限,计算了累积结局信息的 CP 曲线,并与试验数据的原始和转换版本的预设目标标准进行了比较。

结果

当真实效果接近计划效果时,假设效果假设符合目标标准,但当效果小于计划效果时则不符合。当前趋势假设则相反。乐观置信限假设在两者之间似乎提供了一种折衷,当观察到的最终效果与计划效果或更小效果时,其对目标标准的表现良好。

结论

当有希望提前因无效而停止时,当前趋势假设可能是首选假设。可以在有 30%的患者有数据可用时进行中期分析。在使用 CP 做出试验决策时,应该考虑乐观置信限假设,但如果在后勤上可行,应该考虑更晚的中期时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3442/10035140/83dade2aed3c/13063_2023_7202_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3442/10035140/2c15563b8b4d/13063_2023_7202_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3442/10035140/21410f22730a/13063_2023_7202_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3442/10035140/e00e4a58c8a1/13063_2023_7202_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3442/10035140/83dade2aed3c/13063_2023_7202_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3442/10035140/2c15563b8b4d/13063_2023_7202_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3442/10035140/21410f22730a/13063_2023_7202_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3442/10035140/e00e4a58c8a1/13063_2023_7202_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3442/10035140/83dade2aed3c/13063_2023_7202_Fig4_HTML.jpg

相似文献

1
A retrospective analysis of conditional power assumptions in clinical trials with continuous or binary endpoints.回顾性分析具有连续或二分类结局的临床试验中的条件功效假设。
Trials. 2023 Mar 22;24(1):215. doi: 10.1186/s13063-023-07202-6.
2
Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.使用期中 Z 值或置信限控制 I 型和 II 型错误概率的无效性期中监测。
Clin Trials. 2009 Dec;6(6):565-73. doi: 10.1177/1740774509350327. Epub 2009 Nov 23.
3
A systematic survey of randomised trials that stopped early for reasons of futility.一项针对因无效而提前终止的随机试验的系统调查。
BMC Med Res Methodol. 2020 Jan 16;20(1):10. doi: 10.1186/s12874-020-0899-1.
4
Upstrapping to determine futility: predicting future outcomes nonparametrically from past data.向上抽样以确定无效性:从过去的数据中进行非参数预测未来的结果。
Trials. 2024 May 9;25(1):312. doi: 10.1186/s13063-024-08136-3.
5
Optimal futility stopping boundaries for binary endpoints.最佳无效终止边界的二分类结局。
BMC Med Res Methodol. 2024 Mar 28;24(1):80. doi: 10.1186/s12874-024-02190-w.
6
When inferiority meets non-inferiority: implications for interim analyses.当劣势遭遇非劣效性:对期中分析的影响。
Clin Trials. 2012 Oct;9(5):605-9. doi: 10.1177/1740774512453220. Epub 2012 Jul 13.
7
Comparison of futility monitoring guidelines using completed phase III oncology trials.使用已完成的III期肿瘤学试验对无效性监测指南进行比较。
Clin Trials. 2017 Feb;14(1):48-58. doi: 10.1177/1740774516666502. Epub 2016 Sep 22.
8
Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariates.利用短期终点和预后基线协变量信息改进随机试验中的中期决策。
Pharm Stat. 2020 Sep;19(5):583-601. doi: 10.1002/pst.2014. Epub 2020 Apr 5.
9
Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.在具有期中分析和无效性早期终止规则的随机试验中,对估计治疗效果中的偏差进行量化。
Stat Med. 2017 Apr 30;36(9):1506-1518. doi: 10.1002/sim.7242. Epub 2017 Feb 9.
10
Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.具有离散检验统计量和超量考虑的适应性设计
Methods Inf Med. 2015;54(5):434-46. doi: 10.3414/ME14-02-0023. Epub 2015 Oct 2.

引用本文的文献

1
Futility Interim Analyses - A Plea for Simplicity.无效性期中分析——呼吁简化
Ther Innov Regul Sci. 2025 Jul;59(4):650-658. doi: 10.1007/s43441-025-00779-x. Epub 2025 Apr 14.
2
Pragmatic monitoring of emerging efficacy data in randomized controlled trials.在随机对照试验中对新出现的疗效数据进行务实监测。
Clin Trials. 2025 Apr;22(2):155-160. doi: 10.1177/17407745241290729. Epub 2024 Nov 9.
3
Reporting and communication of sample size calculations in adaptive clinical trials: a review of trial protocols and grant applications.

本文引用的文献

1
Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials.条件功效和朋友:(不)计划、(不)盲法样本量重估在确证性试验中的原因和方法。
Stat Med. 2022 Feb 28;41(5):877-890. doi: 10.1002/sim.9288. Epub 2022 Jan 13.
2
A systematic review of the "promising zone" design.一种“有希望区域”设计的系统评价。
Trials. 2020 Dec 4;21(1):1000. doi: 10.1186/s13063-020-04931-w.
3
A study of target effect sizes in randomised controlled trials published in the Health Technology Assessment journal.
适应性临床试验中样本量计算的报告和交流:对试验方案和资助申请的审查。
BMC Med Res Methodol. 2024 Sep 27;24(1):216. doi: 10.1186/s12874-024-02339-7.
一项对发表在《卫生技术评估》杂志上的随机对照试验中目标效应大小的研究。
Trials. 2018 Oct 10;19(1):544. doi: 10.1186/s13063-018-2886-y.
4
Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation.Amaze 研究:一项旨在评估在常规心脏手术基础上附加基于消融设备的迷宫手术对伴有预先存在的心房颤动的患者的临床有效性和成本效益的双盲、多中心随机对照试验。
Health Technol Assess. 2018 Apr;22(19):1-132. doi: 10.3310/hta22190.
5
CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.伴有重度抑郁症的 Screen-Positive 老年人的协作式护理(CASPER plus):一项针对临床效果和成本效益的多中心随机对照试验。
Health Technol Assess. 2017 Nov;21(67):1-252. doi: 10.3310/hta21670.
6
CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.针对筛查呈阳性的亚阈值抑郁症老年患者的协作护理与主动监测(CASPER):一项关于临床有效性和成本效益的多中心随机对照试验
Health Technol Assess. 2017 Feb;21(8):1-196. doi: 10.3310/hta21080.
7
Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial.辅助用吡仑帕奈治疗部分性发作的认知效应:一项随机试验。
Epilepsia. 2016 Feb;57(2):243-51. doi: 10.1111/epi.13279. Epub 2016 Jan 1.
8
A self-managed single exercise programme versus usual physiotherapy treatment for rotator cuff tendinopathy: a randomised controlled trial (the SELF study).一项针对肩袖肌腱病的自我管理单一运动计划与常规物理治疗的对比:一项随机对照试验(SELF研究)
Clin Rehabil. 2016 Jul;30(7):686-96. doi: 10.1177/0269215515593784. Epub 2015 Jul 9.
9
The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma.3Mg 试验:静脉或雾化硫酸镁与安慰剂治疗成人急性重度哮喘的随机对照试验。
Health Technol Assess. 2014 Apr;18(22):1-168. doi: 10.3310/hta18220.
10
An investigation of the impact of futility analysis in publicly funded trials.对公共资助试验中无效性分析的影响的调查。
Trials. 2014 Feb 17;15:61. doi: 10.1186/1745-6215-15-61.